Welcome to INJEX Pharma AG Investor Relations
The INJEX Pharma AG is a manufacturer and distributor of innovative and sustainable health solutions. Product focus are currently needleless injection systems and exclusive agents.
In 2012, the goal of INJEX Pharma AG, is to become the first manufacturer of needle free injections accompanied by strong operating profits.
Earlier this year, the company INJEX Pharma AG, established itself on the exchange of Deutsche Börse in Frankfurt, and is listed as a 1st Quotation Market. A change in General Standard is underway and will be implemented as soon as possible. A securities prospectus will be forthcoming.
INJEX30, the needle free injection, is our product leader. Demand for starter kits is increasing and subsequently so are orders for all related supplies.
Our strongest applications are the use of local anaesthesia, especially in dentistry, and the administration of insulin for diabetics. Recently we have added a new product line in the field of cosmetology & beauty.
The INJEX Pharma AG is focused on international distribution. The company has positioned itself in the key markets using a worldwide network of exclusive distributors. Regions with the highest sales are Asia, Australia, South America and the Middle East.
The INJEX Pharma AG supports their distributors in the country-specific authorization and certification of the products. Next to the FDA approval, which is quite a while in existence, there is a SFDA approval for the Chinese market since April 2013.
ADDITIONAL MARKET: COSMETICS
Yet another strong market with high sales is within the range of cosmetics. With its beauty products the INJEX Pharma AG offers an innovative method to smooth wrinkles.
For more information about the products visit: www.poring-methode.de
Currently the focus is still on the German and the British market; however the development of an international distribution network is already going on.
TEAM AND LOCATIONS
We offer our worldwide network of exclusive distributors, comprehensive training from both Berlin and Miami. We can provide communication in several languages including German, English, French, Arabic, Hebrew and Russian.
The logistics of product development and manufacturing will continue to expand at our offices in Berlin/Brandenburg and Singapore.